HRTX icon

Heron Therapeutics

193 hedge funds and large institutions have $1.1B invested in Heron Therapeutics in 2020 Q1 according to their latest regulatory filings, with 40 funds opening new positions, 81 increasing their positions, 49 reducing their positions, and 42 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding in top 10

Funds holding in top 10:

less first-time investments, than exits

New positions opened: | Existing positions closed:

less funds holding

Funds holding:

7.31% less ownership

Funds ownership: 109.99%102.69% (-7.3%)

39% less call options, than puts

Call options by funds: $5.87M | Put options by funds: $9.66M

53% less capital invested

Capital invested by funds: $2.33B → $1.1B (-$1.23B)

Holders
193
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$5.87M
Puts
$9.66M
Net Calls
Net Calls Change

Top Buyers

1 +$29.1M
2 +$16.4M
3 +$10.2M
4
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
+$6.52M
5
O
OrbiMed
New York
+$6.31M
Name Holding Trade Value Shares
Change
Change in
Stake
76
$852K
77
$831K
78
$803K
79
$797K
80
$775K
81
$771K
82
$770K
83
$733K
84
$726K
85
$648K
86
$614K
87
$613K
88
$604K
89
$595K
90
$584K
91
$560K
92
$546K
93
$534K
94
$511K
95
$508K
96
$505K
97
$495K
98
$475K
99
$475K
100
$459K